Xiaoping Li
Impact in
- Oncology top 5%
- CAR-T cell therapy research
- Drug Transport and Resistance Mechanisms
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Breast Cancer Treatment Studies 9
- Cancer-related molecular mechanisms research 8
- Oncology 27
- CAR-T cell therapy research 5
- Drug Transport and Resistance Mechanisms 5
- Co-authors
- Jiaming Zhang (1 shared paper)Jia‐Da Li (1 shared paper)Ezequiel Neimark (3 shared papers)Frank Chen (3 shared papers)Benjamin L. Shneider (3 shared papers)Xi Zhang (3 shared papers)Jiang F. Zhong (1 shared paper)Ruihao Huang (2 shared papers)
- Journals
- Tumor Biology (4 papers)BMC Cancer (3 papers)Nature Communications (3 papers)Journal of Biological Chemistry (3 papers)BMC Nursing (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Xiaoping Li
148 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 125
- Oncology 711
- Cancer Research 247
- Geriatrics and Gerontology 56
- Genetics 108
- Molecular Biology 745
Countries citing papers authored by Xiaoping Li
This map shows the geographic impact of Xiaoping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoping Li more than expected).
Fields of papers citing papers by Xiaoping Li
This network shows the impact of papers produced by Xiaoping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoping Li. The network helps show where Xiaoping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 155 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 306 | |
| 2 | 2004 | 192 | |
| 3 | 2019 | 173 | |
| 4 | 2007 | 117 | |
| 5 | 2020 | 108 | |
| 6 | 2019 | 87 | |
| 7 | 2001 | 78 | |
| 8 | 2013 | 71 | |
| 9 | 2019 | 66 | |
| 10 | 2019 | 66 | |
| 11 | 2018 | 64 | |
| 12 | 2017 | 62 | |
| 13 | 2023 | 61 | |
| 14 | 2015 | 53 | |
| 15 | 2002 | 51 | |
| 16 | 2006 | 51 | |
| 17 | 2017 | 50 | |
| 18 | 2006 | 47 | |
| 19 | 2011 | 46 | |
| 20 | 2021 | 46 |
About Xiaoping Li
Xiaoping Li is a scholar working on Cancer Research, Oncology, Molecular Biology, Endocrinology, Diabetes and Metabolism and Ecology, Evolution, Behavior and Systematics, having authored 155 papers that have together received 3.3k indexed citations. Recurring topics across this work include Plant Diversity and Evolution (9 papers), Breast Cancer Treatment Studies (9 papers), Cancer-related molecular mechanisms research (8 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers), Plant Ecology and Taxonomy Studies (5 papers), Ovarian cancer diagnosis and treatment (5 papers), CAR-T cell therapy research (5 papers) and Drug Transport and Resistance Mechanisms (5 papers). The work is most often cited by research in Oncology (711 citations), Cancer Research (247 citations), Geriatrics and Gerontology (56 citations), Genetics (108 citations) and Molecular Biology (745 citations). Xiaoping Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jiaming Zhang, Jia‐Da Li, Ezequiel Neimark, Frank Chen, Benjamin L. Shneider, Xi Zhang, Jiang F. Zhong, Ruihao Huang, Cheng Zhang and Lei Gao. Their work appears in journals such as Tumor Biology, BMC Cancer, Nature Communications, Journal of Biological Chemistry and BMC Nursing.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.